Watch Demo

Wearable Artificial Kidney Market Research Report by Disease Stage, Dialysis Type, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

Wearable Artificial Kidney Market Research Report by Disease Stage, Dialysis Type, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:136

  • Report ID:6411042

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Wearable Artificial Kidney Market Research Report by Disease Stage (Acute Renal Disease and End-Stage Renal Disease), Dialysis Type, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

The United States Wearable Artificial Kidney Market size was estimated at USD 31.81 million in 2022 and expected to reach USD 37.14 million in 2023, projecting growth at a CAGR of 18.31% to reach USD 122.14 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Wearable Artificial Kidney Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Wearable Artificial Kidney Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Wearable Artificial Kidney Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Wearable Artificial Kidney Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Wearable Artificial Kidney Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Stage, the market is studied across Acute Renal Disease and End-Stage Renal Disease.

Based on Dialysis Type, the market is studied across Hemodialysis and Peritoneal Dialysis.

Based on End-User, the market is studied across Ambulatory Surgical Centers, Dialysis Centers, and Hospitals.

Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Wearable Artificial Kidney Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Wearable Artificial Kidney Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Wearable Artificial Kidney Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Wearable Artificial Kidney Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Wearable Artificial Kidney Market, including ANSELL LTD, Asahi Kasei Medical Co., Ltd., AWAK Technologies, B. Braun, Baxter International Inc., Blood Purification Technologies Inc., Cardinal Health, Inc., Dynarex Corporation, GE Healthcare, Glove Corporation Bhd, Hartalega Holdings, Hitachi Medical Corporation, KAWASUMI LABORATORIES, INC, Koninklijke Philips N.V., Nanodialysis B.V., Semperit AG Holding, Siemens AG, and Triomed AB.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Wearable Artificial Kidney Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Wearable Artificial Kidney Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Wearable Artificial Kidney Market?
4. What is the competitive strategic window for opportunities in the United States Wearable Artificial Kidney Market?
5. What are the technology trends and regulatory frameworks in the United States Wearable Artificial Kidney Market?
6. What is the market share of the leading vendors in the United States Wearable Artificial Kidney Market?
7. What modes and strategic moves are considered suitable for entering the United States Wearable Artificial Kidney Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Limited availability of donor, leading to limited transplantation
5.1.1.2. Aging population and aging related kidney function
5.1.2. Restraints
5.1.2.1. Stringent U.S. regulatory norms for dialysis products
5.1.3. Opportunities
5.1.3.1. Advancement in bioartificial kidney
5.1.3.2. Increasing early detection and awareness among patients for ambulatory dialysis
5.1.4. Challenges
5.1.4.1. Complications associated with artificial kidney
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Wearable Artificial Kidney Market, by Disease Stage
6.1. Introduction
6.2. Acute Renal Disease
6.3. End-Stage Renal Disease

7. Wearable Artificial Kidney Market, by Dialysis Type
7.1. Introduction
7.2. Hemodialysis
7.3. Peritoneal Dialysis

8. Wearable Artificial Kidney Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Dialysis Centers
8.4. Hospitals

9. California Wearable Artificial Kidney Market
9.1. Introduction

10. Florida Wearable Artificial Kidney Market
10.1. Introduction

11. Illinois Wearable Artificial Kidney Market
11.1. Introduction

12. New York Wearable Artificial Kidney Market
12.1. Introduction

13. Ohio Wearable Artificial Kidney Market
13.1. Introduction

14. Pennsylvania Wearable Artificial Kidney Market
14.1. Introduction

15. Texas Wearable Artificial Kidney Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. ANSELL LTD
17.2. Asahi Kasei Medical Co., Ltd.
17.3. AWAK Technologies
17.4. B. Braun
17.5. Baxter International Inc.
17.6. Blood Purification Technologies Inc.
17.7. Cardinal Health, Inc.
17.8. Dynarex Corporation
17.9. GE Healthcare
17.10. Glove Corporation Bhd
17.11. Hartalega Holdings
17.12. Hitachi Medical Corporation
17.13. KAWASUMI LABORATORIES, INC
17.14. Koninklijke Philips N.V.
17.15. Nanodialysis B.V.
17.16. Semperit AG Holding
17.17. Siemens AG
17.18. Triomed AB

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET DYNAMICS
FIGURE 8. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE STAGE, 2030
FIGURE 12. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2022 VS 2030 (%)
FIGURE 15. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET COMPETITIVE STRATEGIC WINDOW, BY DIALYSIS TYPE, 2030
FIGURE 17. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 22. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 25. CALIFORNIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 26. FLORIDA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 27. ILLINOIS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. NEW YORK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. OHIO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. PENNSYLVANIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. TEXAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 33. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 34. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. CALIFORNIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 23. CALIFORNIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 24. CALIFORNIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 25. CALIFORNIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. FLORIDA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 27. FLORIDA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 28. FLORIDA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 29. FLORIDA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. ILLINOIS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 31. ILLINOIS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 32. ILLINOIS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 33. ILLINOIS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. NEW YORK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 35. NEW YORK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 36. NEW YORK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 37. NEW YORK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. OHIO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 39. OHIO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 40. OHIO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 41. OHIO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. PENNSYLVANIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 43. PENNSYLVANIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 44. PENNSYLVANIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 45. PENNSYLVANIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. TEXAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 47. TEXAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 48. TEXAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
TABLE 49. TEXAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 51. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 52. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 53. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 54. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 55. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 56. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET MERGER & ACQUISITION
TABLE 57. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET INVESTMENT & FUNDING
TABLE 60. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 61. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET: LICENSE & PRICING

Companies Mentioned

ANSELL LTD
Asahi Kasei Medical Co., Ltd.
AWAK Technologies
B. Braun
Baxter International Inc.
Blood Purification Technologies Inc.
Cardinal Health, Inc.
Dynarex Corporation
GE Healthcare
Glove Corporation Bhd
Hartalega Holdings
Hitachi Medical Corporation
KAWASUMI LABORATORIES, INC
Koninklijke Philips N.V.
Nanodialysis B.V.
Semperit AG Holding
Siemens AG
Triomed AB

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.